IKT
Price
$1.05
Change
+$0.09 (+9.38%)
Updated
Dec 5, 6:59 PM EST
VERV
Price
$11.57
Change
-$0.44 (-3.66%)
Updated
Dec 5, 6:59 PM EST
96 days until earnings call
Ad is loading...

Analysis and predictions IKT vs VERV

Header iconIKT vs VERV Comparison
Open Charts IKT vs VERVBanner chart's image
Inhibikase Therapeutics
Price$1.05
Change+$0.09 (+9.38%)
Volume$283.65K
CapitalizationN/A
Verve Therapeutics
Price$11.57
Change-$0.44 (-3.66%)
Volume$689.37K
CapitalizationN/A
View a ticker or compare two or three
IKT vs VERV Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
IKT vs. VERV commentary
Dec 06, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKT is a StrongBuy and VERV is a Hold.

COMPARISON
Comparison
Dec 06, 2023
Stock price -- (IKT: $1.03 vs. VERV: $11.57)
Brand notoriety: IKT and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKT: 122% vs. VERV: 63%
Market capitalization -- IKT: $5.5M vs. VERV: $736.98M
IKT [@Biotechnology] is valued at $5.5M. VERV’s [@Biotechnology] market capitalization is $736.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKT’s FA Score shows that 1 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • IKT’s FA Score: 1 green, 4 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, IKT is a better buy in the long-term than VERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKT’s TA Score shows that 4 TA indicator(s) are bullish while VERV’s TA Score has 2 bullish TA indicator(s).

  • IKT’s TA Score: 4 bullish, 3 bearish.
  • VERV’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, IKT is a better buy in the short-term than VERV.

Price Growth

IKT (@Biotechnology) experienced а +15.00% price change this week, while VERV (@Biotechnology) price change was -3.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.28%. For the same industry, the average monthly price growth was +25.03%, and the average quarterly price growth was +26.76%.

Reported Earning Dates

IKT is expected to report earnings on Nov 14, 2023.

VERV is expected to report earnings on Mar 11, 2024.

Industries' Descriptions

@Biotechnology (+12.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for IKT with price predictions.
OPEN
A.I.dvisor published
a Summary for VERV with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VERV($737M) has a higher market cap than IKT($5.5M). VERV YTD gains are higher at: -40.207 vs. IKT (-65.500). IKT has higher annual earnings (EBITDA): -19.85M vs. VERV (-212.02M). VERV has more cash in the bank: 485M vs. IKT (16.8M). IKT has less debt than VERV: IKT (270K) vs VERV (76.8M). VERV has higher revenues than IKT: VERV (7.63M) vs IKT (0).
IKTVERVIKT / VERV
Capitalization5.5M737M1%
EBITDA-19.85M-212.02M9%
Gain YTD-65.500-40.207163%
P/E RatioN/A3.16-
Revenue07.63M-
Total Cash16.8M485M3%
Total Debt270K76.8M0%
TECHNICAL ANALYSIS
Technical Analysis
IKTVERV
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 23 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MI0.190.02
+11.43%
NFT Limited
IFS19.31-0.10
-0.52%
Intercorp Financial Services
RGA162.81-1.16
-0.71%
Reinsurance Group of America
ACCO5.28-0.13
-2.40%
Acco Brands Corp
SEER1.66-0.05
-2.92%
Seer

IKT and

Correlation & Price change

A.I.dvisor tells us that IKT and VERV have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IKT and VERV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+7.25%
VERV - IKT
33%
Poorly correlated
-3.66%
BPTH - IKT
30%
Poorly correlated
-6.03%
CYTK - IKT
25%
Poorly correlated
-3.98%
TNYA - IKT
24%
Poorly correlated
-4.02%
EVAX - IKT
24%
Poorly correlated
-26.82%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-3.66%
BEAM - VERV
62%
Loosely correlated
-4.47%
CRSP - VERV
61%
Loosely correlated
-1.27%
NTLA - VERV
54%
Loosely correlated
-3.27%
MDGL - VERV
52%
Loosely correlated
+6.04%
PGEN - VERV
50%
Loosely correlated
-0.08%
More